New scaffold device tested to save legs in High-Risk patients
NCT ID NCT07465627
First seen Jun 25, 2026 · Last updated Jul 01, 2026 · Updated 2 times
Summary
This study tests a new device called the Spur scaffold, used with a drug-coated balloon, to treat blocked arteries below the knee in people with chronic limb-threatening ischemia (CLTI). The study includes 40 high-risk patients—those with diabetes or on dialysis—and measures how much the artery recoils (shrinks back) within 15 minutes after treatment. The goal is to see if this approach works better for these difficult-to-treat patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Spur Peripheral Retrievable Scaffold System with a drug-coated balloon
What this could lead to
If successful, this could help doctors understand how to better treat blocked leg arteries in high-risk patients, potentially reducing amputations.
What could go wrong
This is a very small, early study (40 people) that only measures immediate vessel recoil, not long-term outcomes. It may not lead to better treatments or apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LIMB-THREATENING ISCHEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medical University of Graz, Division of Angiology
RECRUITINGGraz, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••